Effect of EPA and DHA supplementation on renal function biomarkers and systolic blood pressure of proteinuric and borderline proteinuric cats diagnosed with chronic kidney disease

Chronic kidney disease (CKD) is common in domestic cats. Feline CKD is characterized by blood parameters, protein loss in urine, and blood pressure. More research is needed to understand novel biomarkers’ contribution. Omega-3 fatty acid supplementation in renal disease has been studied in humans, rats, and dogs, but not in cats. A clinical trial is proposed for cats with proteinuria and CKD to evaluate the therapeutic effect of EPA and DHA supplementation on blood and urine renal biomarkers and blood pressure.

Reference: Integration into Research Grant Fellow EC22-015

Funding source: EveryCat Health Foundation (YSA)

Financing: $33,942

Leading institution: CECAV/UTAD